Docosahexaenoic and eicosapentaenoic acids inhibit the CD28-lymphocyte activation pathway in vitro.
Khalfoun
B
B
Unité Interactions Hôte Greffon, Faculté de Médecine de Tours, France.
Sibué
D
D
Bardos
P
P
Lebranchu
Y
Y
D000911:Antibodies, Monoclonal; D015703:Antigens, CD / Q000276:immunology*; D016718:Arachidonic Acid / Q000494:pharmacology; D018106:CD28 Antigens / Q000276:immunology*; D017252:CD3 Complex / Q000276:immunology; D018914:Cells, Immobilized / Q000187:drug effects / Q000276:immunology; D016572:Cyclosporine / Q000494:pharmacology; D004281:Docosahexaenoic Acids / Q000494:pharmacology*; D015118:Eicosapentaenoic Acid / Q000494:pharmacology*; D006801:Humans; D008213:Lymphocyte Activation / Q000187:drug effects*; D013601:T-Lymphocytes / Q000187:drug effects / Q000276:immunology*
D000911:Antibodies, Monoclonal; D015703:Antigens, CD; D018106:CD28 Antigens; D017252:CD3 Complex; D004281:Docosahexaenoic Acids; D016718:Arachidonic Acid; D016572:Cyclosporine; D015118:Eicosapentaenoic Acid